Literature DB >> 18978

Developments in the pharmacology and therapeutics of parkinsonism.

D B Calne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 18978     DOI： 10.1002/ana.410010202

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  4 in total

1.  In vivo and in vitro dopaminergic effects of three ergoline fragments.

Authors:  J C Koons; J P Long; J G Cannon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

2.  Treatment of Schizophrenia with ergot derivatives.

Authors:  C A Tamminga; M H Schaffer
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

3.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain.

Authors:  J A Javitch; G R Uhl; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

4.  Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.

Authors:  E Melamed; F Hefti; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.